DRD2 and glioblastoma: Recent studies have found that DRD2 signaling functionally alters glucose and lipid metabolisms in glioblastoma cells, and the effect of ONC201 on oxidative phosphorylation and glycolytic activity was dependent on genetic background of tumor cells [42, 43].